177 related articles for article (PubMed ID: 15496419)
1. Human ADA3 binds to estrogen receptor (ER) and functions as a coactivator for ER-mediated transactivation.
Meng G; Zhao Y; Nag A; Zeng M; Dimri G; Gao Q; Wazer DE; Kumar R; Band H; Band V
J Biol Chem; 2004 Dec; 279(52):54230-40. PubMed ID: 15496419
[TBL] [Abstract][Full Text] [Related]
2. Human papilloma virus 16 E6 oncoprotein inhibits retinoic X receptor-mediated transactivation by targeting human ADA3 coactivator.
Zeng M; Kumar A; Meng G; Gao Q; Dimri G; Wazer D; Band H; Band V
J Biol Chem; 2002 Nov; 277(47):45611-8. PubMed ID: 12235159
[TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus oncoprotein E6 inactivates the transcriptional coactivator human ADA3.
Kumar A; Zhao Y; Meng G; Zeng M; Srinivasan S; Delmolino LM; Gao Q; Dimri G; Weber GF; Wazer DE; Band H; Band V
Mol Cell Biol; 2002 Aug; 22(16):5801-12. PubMed ID: 12138191
[TBL] [Abstract][Full Text] [Related]
4. MICoA, a novel metastasis-associated protein 1 (MTA1) interacting protein coactivator, regulates estrogen receptor-alpha transactivation functions.
Mishra SK; Mazumdar A; Vadlamudi RK; Li F; Wang RA; Yu W; Jordan VC; Santen RJ; Kumar R
J Biol Chem; 2003 May; 278(21):19209-19. PubMed ID: 12639951
[TBL] [Abstract][Full Text] [Related]
5. Human ADA3 regulates RARalpha transcriptional activity through direct contact between LxxLL motifs and the receptor coactivator pocket.
Li CW; Ai N; Dinh GK; Welsh WJ; Chen JD
Nucleic Acids Res; 2010 Sep; 38(16):5291-303. PubMed ID: 20413580
[TBL] [Abstract][Full Text] [Related]
6. Stimulatory cross-talk between NFAT3 and estrogen receptor in breast cancer cells.
Zhang H; Xie X; Zhu X; Zhu J; Hao C; Lu Q; Ding L; Liu Y; Zhou L; Liu Y; Huang C; Wen C; Ye Q
J Biol Chem; 2005 Dec; 280(52):43188-97. PubMed ID: 16219765
[TBL] [Abstract][Full Text] [Related]
7. Estrogen receptor (ER) beta modulates ERalpha-mediated transcriptional activation by altering the recruitment of c-Fos and c-Jun to estrogen-responsive promoters.
Matthews J; Wihlén B; Tujague M; Wan J; Ström A; Gustafsson JA
Mol Endocrinol; 2006 Mar; 20(3):534-43. PubMed ID: 16293641
[TBL] [Abstract][Full Text] [Related]
8. Identification of a peptide that disrupts hADA3-E6 interaction with implications in HPV induced cancer therapy.
Chand V; Kapoor A; Kundu S; Nag A
Life Sci; 2022 Jan; 288():120157. PubMed ID: 34801511
[TBL] [Abstract][Full Text] [Related]
9. Interaction of the tumor metastasis suppressor nonmetastatic protein 23 homologue H1 and estrogen receptor alpha alters estrogen-responsive gene expression.
Curtis CD; Likhite VS; McLeod IX; Yates JR; Nardulli AM
Cancer Res; 2007 Nov; 67(21):10600-7. PubMed ID: 17975005
[TBL] [Abstract][Full Text] [Related]
10. CCDC62/ERAP75 functions as a coactivator to enhance estrogen receptor beta-mediated transactivation and target gene expression in prostate cancer cells.
Chen M; Ni J; Chang HC; Lin CY; Muyan M; Yeh S
Carcinogenesis; 2009 May; 30(5):841-50. PubMed ID: 19126643
[TBL] [Abstract][Full Text] [Related]
11. Estrogen response element-dependent regulation of transcriptional activation of estrogen receptors alpha and beta by coactivators and corepressors.
Klinge CM; Jernigan SC; Mattingly KA; Risinger KE; Zhang J
J Mol Endocrinol; 2004 Oct; 33(2):387-410. PubMed ID: 15525597
[TBL] [Abstract][Full Text] [Related]
12. The aryl hydrocarbon receptor (AHR)/AHR nuclear translocator (ARNT) heterodimer interacts with naturally occurring estrogen response elements.
Klinge CM; Bowers JL; Kulakosky PC; Kamboj KK; Swanson HI
Mol Cell Endocrinol; 1999 Nov; 157(1-2):105-19. PubMed ID: 10619402
[TBL] [Abstract][Full Text] [Related]
13. Inhibiting proteasomal proteolysis sustains estrogen receptor-alpha activation.
Fan M; Nakshatri H; Nephew KP
Mol Endocrinol; 2004 Nov; 18(11):2603-15. PubMed ID: 15284335
[TBL] [Abstract][Full Text] [Related]
14. Expression of estrogen receptor (ER)-alpha and ER-beta in normal and malignant prostatic epithelial cells: regulation by methylation and involvement in growth regulation.
Lau KM; LaSpina M; Long J; Ho SM
Cancer Res; 2000 Jun; 60(12):3175-82. PubMed ID: 10866308
[TBL] [Abstract][Full Text] [Related]
15. Tale of a multifaceted co-activator, hADA3: from embryogenesis to cancer and beyond.
Chand V; Nandi D; Mangla AG; Sharma P; Nag A
Open Biol; 2016 Sep; 6(9):. PubMed ID: 27605378
[TBL] [Abstract][Full Text] [Related]
16. Estrogen response element and the promoter context of the human and mouse lactoferrin genes influence estrogen receptor alpha-mediated transactivation activity in mammary gland cells.
Stokes K; Alston-Mills B; Teng C
J Mol Endocrinol; 2004 Oct; 33(2):315-34. PubMed ID: 15525592
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional regulation of the estrogen-inducible pS2 breast cancer marker gene by the ERR family of orphan nuclear receptors.
Lu D; Kiriyama Y; Lee KY; Giguère V
Cancer Res; 2001 Sep; 61(18):6755-61. PubMed ID: 11559547
[TBL] [Abstract][Full Text] [Related]
18. Identification of transcriptional and phosphatase regulators as interaction partners of human ADA3, a component of histone acetyltransferase complexes.
Zencir S; Sike A; Dobson MJ; Ayaydin F; Boros I; Topcu Z
Biochem J; 2013 Mar; 450(2):311-20. PubMed ID: 23167988
[TBL] [Abstract][Full Text] [Related]
19. Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription.
Shang Y; Hu X; DiRenzo J; Lazar MA; Brown M
Cell; 2000 Dec; 103(6):843-52. PubMed ID: 11136970
[TBL] [Abstract][Full Text] [Related]
20. HPV16 E6-induced and E6AP-dependent inhibition of the transcriptional coactivator hADA3 in human cervical carcinoma cells.
Hu Y; Ye F; Lu W; Hong D; Wan X; Xie X
Cancer Invest; 2009 Mar; 27(3):298-306. PubMed ID: 19194825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
